Practice Management News

LAS VEGAS — The cost associated with treating inflammatory bowel disease “significantly increased” from 2009 to 2019 and was largely attributed to the annual cost of biologics, a presenter reported at the Crohn’s & Colitis Congress.

LAS VEGAS —A presenter at the Crohn’s & Colitis Congress outlined some of the newer therapies that have expanded the current “arsenal of tools” for the treatment of inflammatory bowel disease.

LAS VEGAS — Collaborative, multidisciplinary care strategies optimize the treatment and management of patients with very early-onset inflammatory bowel disease, a presenter reported at the Crohn’s & Colitis Congress.

LAS VEGAS — In a Healio exclusive, Stacy A. Ogbeide, PsyD, MS, MSCP, ABPP, CSOWM, discusses ways in which the health care system — and clinicians themselves — can prioritize self-care and create a more “enjoyable” work environment.

Inflammatory bowel disease phenotype and behavior vary by race and immigration status, with foreign-born patients of all races experiencing less severe disease and later onset than those born in the U.S., researchers reported.

In the latest installment of Healio’s diversity, equity and inclusion video series with the ASGE, Catherine T. Hudson, MD, addressed how to combat emerging stigma around new anti-obesity medications such as glucagon-like peptide agonists.

CMS has finalized a new final rule that aims to shorten prior authorization timelines and streamline processes to remove barriers to patient care, according to a press release.

On Oct. 24, 2023, Debra Houry, MD, MPH, chief medical officer and deputy director for program and science at the CDC, issued a grim warning to members of the media: Burnout among health care workers “has reached crisis levels.”

WAILEA, Hawaii — Health care law trends in 2023 were telehealth, whistleblowers, physician referrals and a more intense focus on compliance by providers and practices, according to a law expert speaking at Hawaiian Eye/Retina 2024.

The incorporation of low-dose esketamine to propofol-based sedation reduced desaturation and hypotension events by approximately 61% among patients undergoing same-visit bidirectional endoscopy, researchers reported.